Apellis Pharmaceuticals Inc Net Income per Employee (APLS), current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Apellis Pharmaceuticals Inc   (NASDAQ: APLS)
 

Apellis Pharmaceuticals Inc Net Income per Employee

APLS's Quarterly Results, Trends, Rankings, Statistics
Apellis Pharmaceuticals Inc 's Income per employee fell in the first quarter 2026 on a trailing twelve month basis to $ 180,337, but the productivity of Apellis Pharmaceuticals Inc 's 739 employees remained above the company average.
The Healthcare sector has seen employees of 44 other companies achieving higher income per employee. While income per employee total ranking has improved so far to 626, from total ranking in previous quarter at 1503.


What is Income per Employee Ratio?





Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

APLS Net Income per Employee (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter		 (Mar 31 2025)
I. Quarter
Y / Y Net Income Change - - - - -
Net Income per Employee (TTM) $ 180,337 30,295 60,874 -308,760 -302,679
APLS's Total Ranking # 626 # 1503 # 1131 # 2953 # 2942
Seq. Net Income Change - - - - -

APLS Company Profile >> Back to APLS Efficiency Comparisons >> Compare APLS Net Income per Employee to its Competitors

APLS Net Income per Employee Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 45
Healthcare Sector # 74
Overall Market # 626

Net Income per Employee Statistics
High Average Low
$ 180,337 $ -489,037 $ -1,009,951
(Mar 31 2026)   (Dec 31 2021)







Companies with similar Income per Employee for 12 month ending Mar 31 2026, within Healthcare Sector Income per Employee Income 12 month ending Mar 31 2026Number of Employees Mar 31 2026
Abeona Therapeutics Inc   292,641.59 $ 66.137  Million 226 
Regeneron Pharmaceuticals Inc   287,047.37 $ 4,423.400  Million 15,410 
Adma Biologics Inc   255,570.32 $ 165.354  Million 647 
Indivior Pharmaceuticals Inc   252,000.00 $ 252.000  Million 1,000 
Dariohealth Corp   246,884.85 $ 40.736  Million 165 
Lantheus Holdings Inc   233,890.19 $ 279.031  Million 1,193 
Interpace Biosciences Inc   231,852.94 $ 23.649  Million 102 
Alnylam Pharmaceuticals Inc   230,886.80 $ 577.217  Million 2,500 
Protagenic Therapeutics Inc new  228,000.00 $ 1.368  Million 6 
Bristol myers Squibb Company  223,723.08 $ 7,271.000  Million 32,500 
Entrada Therapeutics Inc   221,947.37 $ 33.736  Million 152 
Community Health Systems Inc   201,935.48 $ 626.000  Million 3,100 
Standard Biotools Inc   201,041.13 $ 78.205  Million 389 
Kiniksa Pharmaceuticals International Plc  199,612.02 $ 73.058  Million 366 
Xeris Biopharma Holdings Inc   199,000.00 $ 12.935  Million 65 
Lensar Inc   195,980.00 $ 29.397  Million 150 
Transmedics Group Inc   191,452.12 $ 171.924  Million 898 
Biogen Inc   182,920.00 $ 1,371.900  Million 7,500 
Zoetis Inc   182,275.86 $ 2,643.000  Million 14,500 
Apellis Pharmaceuticals Inc   180,336.94 $ 133.269  Million 739 
Therapeuticsmd Inc   179,000.00 $ 0.179  Million 1 
Collegium Pharmaceutical Inc   177,184.40 $ 74.949  Million 423 
Intuitive Surgical Inc   176,188.24 $ 2,998.900  Million 17,021 
Johnson and Johnson  149,431.82 $ 21,040.000  Million 140,800 
Iradimed Corporation  142,232.36 $ 23.611  Million 166 
Puma Biotechnology Inc   136,223.46 $ 24.384  Million 179 
Resmed Inc   133,646.97 $ 1,519.566  Million 11,370 
Carlisle Companies Incorporated  122,898.31 $ 725.100  Million 5,900 
Merck and Co Inc   119,133.33 $ 8,935.000  Million 75,000 
Veracyte Inc   116,573.51 $ 88.013  Million 755 


Date modified: 2026-08-30T14:57:51+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.